Impact of COVID-19 on New Mexico Harm Reduction Services: Challenges and Recommendations

Reta, Anita; Nelson, Leah; Rose, Rachel V.; Carrejo, Valerie; Bhatt, Snehal

doi:10.21203/rs.3.rs-139091/v1

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The global impact of coronavirus disease 2019 (COVID-19) pandemic is unprecedented, causing disproportionate deaths and social suffering to the world populations. In particular, COVID-19-related restrictions have led to an increase in use of drugs and alcohol, increased prices, access to impure drugs, switching to other substances, increased use of new drugs, and decreased use of others (Dubey et al, 2020; Enns et al, 2020; Farhoudian et al, 2020; MacKinnon et al, 2020; Reta et al, 2021; Wardell et al, 2020). In addition, because of reduced trafficking of drugs, the purity of drugs has reduced, which has led to an increase in the amount bought and used by people with substance use disorders (SUDs) United Nations Office on Drugs and Crime, 2020).…”

Section: Introductionmentioning

confidence: 99%

“…Because of lockdown and physical “social” distancing, the level of contact between patients and drug services reduced drastically on short notice. Evidence shows that lockdown led to reduced access to treatment services including harm reduction and psychosocial interventions (Croxford et al, 2021; Dubey et al, 2020; Enns et al, 2020; MacKinnon et al, 2020; Reta et al, 2021; Wardell et al, 2020). In addition, pharmacies have been encouraged to reduce close contact with patients, with many switched from daily supervised consumption to large quantities of take-home medications.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection?

Owiti¹,

Benson²,

Maplanka³

et al. 2022

UJAN

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic has led to not only increase in substance misuse, substance use disorder, and risk of overdose but also lack of access to treatment services. Due to lack of knowledge of the course and impact of COVID-19 and outcomes of it’s interactions with existing treatments, the Substance Misuse Service Team initiated a safety improvement project to review the safety of opioid substitution treatment, particularly the safety of methadone. This preliminary retrospective cross-sectional audit of safety improvement intiative underscores the importance of providing treatment services to those with opioid use disorders and that methadone is safe among this population with a high burden of comorbidity, most of which leads to negative outcomes from COVID-19. The outcomes show that patients who have COVID-19 should continue with opioid substitution treatment with methadone. Although treatment with methadone is safe, symptomatic patients should be monitored. In addition, patients who take methadone at home should be educated on the risk of overdose due to, and adverse outcomes from, COVID-19 infection. Patients should monitor themselves using pulse oximeter for any signs of hypoxia.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection?

Owiti¹,

Benson²,

Maplanka³

et al. 2022

UJAN

View full text Add to dashboard Cite

show abstract

Social Vulnerabilities and Spatial Access to Primary Healthcare through Car and Public Transportation System in the Albuquerque, NM, Metropolitan Area: Assessing Disparities through GIS and Multilevel Modeling

2022

View full text Add to dashboard Cite

Primary healthcare (PHC) is a keystone component of population health. However, inequities in public transportation access hinder equitable usage of PHC services by minoritized populations. Using the multimodal enhanced 2-step floating catchment area method and data in 2018 and 2019 for spatial access to PHC providers ( n = 1166) and social vulnerability markers through census block ( n = 543) and tract data ( n = 226), a generalized linear mixed-effect model (GLMEM) was constructed to test the effects of sociodemographic and community area correlates on both car and bus transit spatial access to PHC in the Albuquerque, New Mexico (NM) metropolitan area. Results for bus spatial access to PHC showed lower access for Hispanics ( B = − 0.097 ± 0.029 [− 0.154, − 0.040]) and non-Hispanic Whites ( B = − 0.106 ± 0.032 [− 0.169, − 0.043]) and a positive association between single-family households and bus spatial access ( B = 1.573 ± 0.349 [0.866, 2.261]). Greater disability vulnerability ( B = − 0.569 ± 0.173 [− 0.919, − 0.259]) and language vulnerability ( B = − 0.569 ± 0.173 [− 0.919, − 0.259]) were associated with decreased bus spatial access. For car spatial access to PHC, greater SES vulnerability ( B = − 0.338 ± 0.021 [− 1.568, -0.143]), disability ( B = − 0.721 ± .092 [− 0.862, − 0.50 9]), and language vulnerability ( B = − 0.686 ± 0.172 [− 1.044, − 0.362]) were associated with less car spatial access. Results indicate a disproportionate burden of low PHC access among disadvantaged population groups who rely heavily on public transportation. These results necessitate targeted interventions to reduce these disparities in access to PHC.

show abstract

Impact of COVID-19 on New Mexico Harm Reduction Services: Challenges and Recommendations

Cited by 2 publications

References 4 publications

Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection?

Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection?

Social Vulnerabilities and Spatial Access to Primary Healthcare through Car and Public Transportation System in the Albuquerque, NM, Metropolitan Area: Assessing Disparities through GIS and Multilevel Modeling

Contact Info

Product

Resources

About